Innovations Spotlight

08/12/2019

eHospital's Journey from Concept to Emerging Enterprise-wide Luminary

Innovation has long been one of the hallmarks of Cleveland Clinic. The innovations and medical “firsts” frequently attributed to Cleveland Clinic include surgical firsts, such as the world’s first coronary angiography, the first minimally invasive aortic heart valve surgery, and the first kidney surgery performed through a patient’s
navel. But Cleveland Clinic’s expertise and innovations stretch far beyond the surgery suite.

08/08/2019

The Gamification of Healthcare

As consumers demand more patient-centered healthcare, gaming technologies are delivering fun, innovative way to keep them engaged. The intersection of these two sectors is providing opportunities to improve outcomes by making the process more entertaining. While to most it seems odd that healthcare and gaming could ever cross paths, those inside this budding industry co-op can’t understand why it hasn’t happened sooner.

08/05/2019

Lifelong Innovation: The TMAO Story

A member of Cleveland Clinic’s staff since 1997, Stanley Hazen, MD, PhD, is both a practicing physician and researcher with many leadership roles. He has published over 400 peer-reviewed manuscripts and is counted amongst some of the most highly cited investigators in the country – attesting to the high impact his studies have made. But his thirst for research has yet to be quenched.

08/02/2019

Neighbors Helping Neighbors

On Thursday, July 24, the staff of CCI took place in a day of service in partnership with Fairfax Renaissance Development Corporation (FRDC) to assist members of our community. Team members came together to help two wonderful neighbors work on the exterior of their homes, as well as the local park – including painting, staining decks, pruning and gardening, and mulching.

07/31/2019

Anesthesiologists Invent Device to Tackle the Problem of Airway Management

Drs. Rafi Avitsian and Andrew Zura are passionate about what they do and how they improve patient care. Both anesthesiologists at Cleveland Clinic, Dr. Avitsian is the program director for the Neuroanesthesiology Fellowship, and Dr. Zura is the section head for ENT Anesthesia. For these physicians, innovation means finding a way to improve airway management.

07/30/2019

HDL Quality Over Quantity in Prediction of Major Adverse Cardiac Events

Jonathan Smith, PhD, is the Geoffrey Gund Endowed Chair for Cardiovascular Research at Lerner Research Institute. With Cleveland Clinic since 2002, Smith has made major strides in his work toward cardiovascular excellence. Smith’s latest project involves an ApoA1 Exchange Rate Assay as a Diagnostic tool for Major Adverse Cardiovascular Events (MACE).

07/29/2019

The Changing Role of Consumerization in Healthcare

Let’s face it: Patients are taking a greater role in their healthcare and are demanding more. More access to caregivers, more transparency, more data, more options. Today, we don’t have time to schedule an appointment for three months from now; we want to be seen in 30 minutes.

07/29/2019

Ventures-Investment-Innovations Team Rides in Velosano

Congratulations to all of the riders, volunteers and donors from the CC Ventures Investment Innovation Velosano team who took part in the ride for the cure over July 20-21. This was an impressive showing with nearly 100% participation from all three departments. We had 36 riders ride 2,032 miles over the weekend

07/18/2019

Temporal Importance in the Reinvention of Radiation Therapy

Jacob Scott, MD, DPhil, of Lerner Reserach Institute is not your average doctor. In his every day practice, Dr. SCott leverages a multi-dimensional background. From his time studying astrophysics and nuclear engineering while working aboard a submarine, he utilizes his expertise in computer science and mathematical biology to improve patient care. With two innovative technologies, Jacob looks to maximize radiation therapy efficacy and minimize toxicity in his patients.

07/17/2019

O’Neill Testifies in Front of Senate Judiciary Committee

In early June in Washington, D.C., Cleveland Clinic Innovations (CCI) Executive Director Pete O’Neill testified in front of a Senate Judiciary Committee on the state of patent eligibility in America. One of 45 witnesses across three days of testimony, O’Neill spoke to Cleveland Clinic’s perspective on the importance of having confidence that an issued patent that follows guidance of the USPTO will not be invalidated based on court case-law. His testimony addressed Cleveland Clinic’s experience with patenting the diagnostic MPO test, which led to the creation of Cleveland HeartLab. Specifically, he spoke about cases before federal district courts whereby the court rulings resulted in losing the protection of the MPO patents.

< 1 2 3 4 5 6 7 8 9 10 >

Get In Touch With Us

Name

Ready to INVENT®? Download the Invention Disclosure Form Today.

Learn More

Save the Date for MIS2017: October 23-25 Genomics & Precision Medicine

Learn More